Company page
Marker Therapeutics, Inc.
Marker Therapeutics, Inc. is a public company traded under the ticker MRKR in the American market. The company has a market capitalization of approximately $22.2 million. Marker Therapeutics focuses on developing innovative therapies in the field of cancer treatment.
- Ticker
- MRKR:NASDAQ
- Asset type
- Stock
- Market cap
- $22.2M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD